COVID-19 news – April 2020 Find on this page the news of April related to the COVID-19 epidemic. PRESS AND MEDIA • 29/04/20 – Le remdesivir accélérerait de 31% le temps de rétablissement des malades du Covid-19. Le Vif – First World Pharma • 29/04/20 – Vaccins anti-covid: les 4 procédés les plus prometteurs. Nature – Le Soir •…
Accessia pharma : a dedicated site for your GMP production Accessia Pharma has been designed to allow the healthcare actors to maintain in Wallonia their GMP manufacturing. Accessia Pharma has been designed to allow the healthcare actors to maintain in Wallonia their GMP manufacturing. The major issue for small companies…
Launch of the European project CE4BIG Cluster Excellence for Business Innovation and Growth in the Health Sector The project CE4BIG – Cluster Excellence for Business Innovation and Growth in the Health Sector, was selected to receive funding under the EU COSME “European Cluster Excellence” initiative, which aims to foster cluster collaboration on…
DNAlytics is currently involved in several projects related to the fight against COVID-19 Support for the validation of treatments and development of a contagion detection application The members of the cluster keep working initiatives aimed at ending the crisis. This is the case of DNAlytics, which is currently involved in several…
COVID-19 news – March 2020 Find on this page the news of March related to the COVID-19 epidemic. PRESS AND MEDIA *Articles available in french* • 31/03/20 – Une usine de production et de décontamination de masques en Wallonie. Le Soir – L’Echo – RTBF • 31/03/20 – Coronavirus: la Belgique va tester quatre thérapies prometteuses. Le Soir •…
Mithra Announces Commercial Launch of Myring™ in Germany, the biggest market in Europe Mithra, a company dedicated to Women’s Health announced the commercial launch of Myring™ in Germany, which is the largest European market and the second worldwide in terms of sales volume. Successful launch of Mithra’s hormonal contraceptive ring…
BREAKING NEWS! iTeos Therapeutics closes $125 Million Series B2 Financing iTeos Therapeutics, biotech company in our Walloon ecosystem, raised $125 million to support the clinical development of its two innovative cancer immunotherapy programs. Biotech company iTeos Therapeutics announced Wednesday that it has closed a $125 million Series B2 financing. Proceeds…
Authorisation scheme for the export of medical equipment from the EU Export outside the EU of the listed medical devices is now subject to a prior authorisation regime. Discover here the guidance note to Member States related to Commission implementing Regulation (EU) 2020/402 making the exportation of certain products subject to the…
Events and working process : update COVID-19 We will keep you posted on any further development! In the current environment, our priority is to reduce the risk of infection for our members, partners and employees. In order to eliminate any risk, BioWin events planned for March and April 2020 have been cancelled or postponed. We’ll keep you…
Ayming Belgium becomes the first partner of BioWin This novel cooperation enables the health cluster of Wallonia to supplement and strengthen its offer of support to the ecosystem stakeholders To support the growth of its members on specific aspects relating to their development, BioWin wishes to cooperate more proactively with its “associate” members, service companies…
Business Village Ecolys
Avenue d’Ecolys 2
5020 Namur (Belgium)
Email : contact@biowin.org
VAT BE 0882.768.591
Website by Monkeys not Donkeys
© 2024 BioWin.
